192 related articles for article (PubMed ID: 38315756)
1. Modulation of Metal Homeostasis for Cancer Therapy.
Yang Y; Fan H; Guo Z
Chempluschem; 2024 Jun; 89(6):e202300624. PubMed ID: 38315756
[TBL] [Abstract][Full Text] [Related]
2. Metal Ions in Alzheimer's Disease: A Key Role or Not?
Liu Y; Nguyen M; Robert A; Meunier B
Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
[TBL] [Abstract][Full Text] [Related]
3. Novel chelators for cancer treatment: where are we now?
Merlot AM; Kalinowski DS; Richardson DR
Antioxid Redox Signal; 2013 Mar; 18(8):973-1006. PubMed ID: 22424293
[TBL] [Abstract][Full Text] [Related]
4. Advances on Chelation and Chelator Metal Complexes in Medicine.
Kontoghiorghes GJ
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260293
[TBL] [Abstract][Full Text] [Related]
5. Copper and Copper Complexes in Tumor Therapy.
Wang Y; Tang T; Yuan Y; Li N; Wang X; Guan J
ChemMedChem; 2024 Jun; 19(11):e202400060. PubMed ID: 38443744
[TBL] [Abstract][Full Text] [Related]
6. New applications of old metal-binding drugs in the treatment of human cancer.
Schmitt SM; Frezza M; Dou QP
Front Biosci (Schol Ed); 2012 Jan; 4(1):375-91. PubMed ID: 22202066
[TBL] [Abstract][Full Text] [Related]
7. Regulation of copper and iron homeostasis by metal chelators: a possible chemotherapy for Alzheimer's disease.
Robert A; Liu Y; Nguyen M; Meunier B
Acc Chem Res; 2015 May; 48(5):1332-9. PubMed ID: 25946460
[TBL] [Abstract][Full Text] [Related]
8. Novel metals and metal complexes as platforms for cancer therapy.
Frezza M; Hindo S; Chen D; Davenport A; Schmitt S; Tomco D; Dou QP
Curr Pharm Des; 2010 Jun; 16(16):1813-25. PubMed ID: 20337575
[TBL] [Abstract][Full Text] [Related]
9. Metal Complexes or Chelators with ROS Regulation Capacity: Promising Candidates for Cancer Treatment.
Li X; Wang Y; Li M; Wang H; Dong X
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011380
[TBL] [Abstract][Full Text] [Related]
10. Transition metal chelators, pro-chelators, and ionophores as small molecule cancer chemotherapeutic agents.
Steinbrueck A; Sedgwick AC; Brewster JT; Yan KC; Shang Y; Knoll DM; Vargas-Zúñiga GI; He XP; Tian H; Sessler JL
Chem Soc Rev; 2020 Jun; 49(12):3726-3747. PubMed ID: 32525153
[TBL] [Abstract][Full Text] [Related]
11. Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives.
Fasae KD; Abolaji AO; Faloye TR; Odunsi AY; Oyetayo BO; Enya JI; Rotimi JA; Akinyemi RO; Whitworth AJ; Aschner M
J Trace Elem Med Biol; 2021 Sep; 67():126779. PubMed ID: 34034029
[TBL] [Abstract][Full Text] [Related]
12. Redox cycling metals: Pedaling their roles in metabolism and their use in the development of novel therapeutics.
Kalinowski DS; Stefani C; Toyokuni S; Ganz T; Anderson GJ; Subramaniam NV; Trinder D; Olynyk JK; Chua A; Jansson PJ; Sahni S; Lane DJ; Merlot AM; Kovacevic Z; Huang ML; Lee CS; Richardson DR
Biochim Biophys Acta; 2016 Apr; 1863(4):727-48. PubMed ID: 26844773
[TBL] [Abstract][Full Text] [Related]
13. Exploiting Cancer Metal Metabolism using Anti-Cancer Metal- Binding Agents.
Merlot AM; Kalinowski DS; Kovacevic Z; Jansson PJ; Sahni S; Huang ML; Lane DJR; Lok H; Richardson DR
Curr Med Chem; 2019; 26(2):302-322. PubMed ID: 28685681
[TBL] [Abstract][Full Text] [Related]
14. Iron-targeting antitumor activity of gallium compounds and novel insights into triapine(®)-metal complexes.
Chitambar CR; Antholine WE
Antioxid Redox Signal; 2013 Mar; 18(8):956-72. PubMed ID: 22900955
[TBL] [Abstract][Full Text] [Related]
15. Copper homeostasis: Emerging target for cancer treatment.
Li Y
IUBMB Life; 2020 Sep; 72(9):1900-1908. PubMed ID: 32599675
[TBL] [Abstract][Full Text] [Related]
16. Prochelator strategies for site-selective activation of metal chelators.
Oliveri V; Vecchio G
J Inorg Biochem; 2016 Sep; 162():31-43. PubMed ID: 27297691
[TBL] [Abstract][Full Text] [Related]
17. Copper in medicine: homeostasis, chelation therapy and antitumor drug design.
Wang T; Guo Z
Curr Med Chem; 2006; 13(5):525-37. PubMed ID: 16515519
[TBL] [Abstract][Full Text] [Related]
18. Metals and metal derivatives in medicine.
Colotti G; Ilari A; Boffi A; Morea V
Mini Rev Med Chem; 2013 Feb; 13(2):211-21. PubMed ID: 23438056
[TBL] [Abstract][Full Text] [Related]
19. The impact of chelating compounds on Cu
Mazur T; Malik M; Bieńko DC
J Inorg Biochem; 2024 Aug; 257():112601. PubMed ID: 38744143
[TBL] [Abstract][Full Text] [Related]
20. Metalloimmunology: The metal ion-controlled immunity.
Wang C; Zhang R; Wei X; Lv M; Jiang Z
Adv Immunol; 2020; 145():187-241. PubMed ID: 32081198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
